Biomunex Pharmaceuticals has established its U.S. subsidiary, Biomunex Pharmaceuticals Inc., in Cambridge, MA. The opening of this subsidiary is the first step in the company’s strategy to expand Biomunex’ activities in the U.S., with the initial focus on facilitating Research & Development partnerships and business development activities with pharmaceutical companies and leading academic institutions.    “Following our recent licensing agreement with Sanofi for the generation and optimiza...